OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Immunology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Editorial Board	374
Differential immune responses behind different celiac disease manifestations	106
Three’s company: The cooperative signals behind the differentiation of Th9 cells	96
COVID-19 in Latin America: Clinical and immunological insights, vaccine development, and lessons for pandemic preparedness	92
Exploiting antifungal immunity in the clinical context	88
Cellular stress and macrophage activation	85
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity	83
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells	83
Editorial Board	73
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges	69
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi	68
Microbial metabolites and immunotherapy: Basic rationale and clinical indications	64
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity	62
Local and Cell-intrinsic complement: The new player in cancer progression	59
Pyroptosis modulation by bacterial effector proteins	56
Aging of lymphoid stromal architecture impacts immune responses	56
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity	50
Immunity to pathogenic fungi in the eye	50
IL-1 family members as regulators of lymphoid type-2 immunity in cancer	48
Therapeutic immune tolerance for central nervous system autoimmune diseases – Prospects, challenges and pitfalls	45
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity	43
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease	42
Pyroptosis: A road to next-generation cancer immunotherapy	42
Pyroptosis and the cellular consequences of gasdermin pores	41
The noncanonical inflammasome-induced pyroptosis and septic shock	40

Western diet influences on microbiome and carcinogenesis	39
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment	39
Interplay between the complement system and other immune pathways in the tumor microenvironment	38
The paradox of aging: Aging-related shifts in T cell function and metabolism	35
Immunity to fungi: Editorial overview	35
Autoimmune diabetes and targets for immunomodulation	34
Neuroimmune interactions between itch neurons and skin microbes	34
Interleukin-1β and cancer immune response	34
TREM2: A new player in the tumor microenvironment	33
Adaptive NK cell response to human cytomegalovirus: Facts and open issues	33
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases	32
The evolving biology of cross-presentation	32
Sialic acid and Siglec receptors in tumor immunity and immunotherapy	31
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy	31
Antigen discovery for the development of cancer immunotherapy	31
Diverse IL-9-secreting T helper cells direct responses in the allergic lung	29
Thymus aging and immune reconstitution, progresses and challenges	29
The multifaceted role of B lymphocytes in type 1 diabetes	29
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders	28
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs	28
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity	28
T cell control of SARS-CoV-2: When, which, and where?	28
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination	28
Introduction to the Special Issue: Nutrition, microbiota and immunity	28
T cell fate decisions during memory cell generation with aging	27
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?	27
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy	27
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity	27
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice	26
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells	26
Editorial Board	26
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy	25